Filters
Showing the single result
-
Acute Myeloid Leukemia (AML) -The Changing Landscape of Treatment in AML, Executive Deck 2022
$5,000.00 – $25,000.00Acute myelogenous leukemia (AML) Disease Landscape provides comprehensive market intelligence with epidemiology, keen insight into current treatment paradigms, in-depth pipeline coverage ( ~ 500 unique industry-sponsored studies) and clinical trial landscape supported by detailed recent results from ASH 2022, ASCO 2022 and EHA 2022. The drugs are further classified according to the class of therapies: antibody drug conjugates, bispecific antibodies, tri-specific and monoclonal antibodies, CAR-T therapies & T cells therapies, vaccines, small molecules and others.
Product Search
Filter by price
Top rated products
Product categories
- Endocrinology 1
- Pipeline Analytics Report 1
- Disease Competitive Landscape Monitoring 1
- Metabolic Disorders 1
- Therapeutic Area 18
- Musculoskeletal Diseases 1
- Oncology 2
- Hematology 2
- Market Forecast 16
- Respiratory Diseases 1
- Ophthalmology 1
- Orthopedics 1
- Central Nervous System 7
- Inflammatory 1
- Genetic Disorders 1
- Renal Diseases / Nephrology 6